4.5 Article

Fear of cancer recurrence and its predictors among cervical cancer survivors

期刊

JOURNAL OF GYNECOLOGIC ONCOLOGY
卷 28, 期 6, 页码 -

出版社

KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY
DOI: 10.3802/jgo.2017.28.e72

关键词

Uterine Cervical Neoplasms; Survivors; Fear; Recurrence; Risk Factors

资金

  1. Faculty of Medicine, Prince of Songkla University, Thailand

向作者/读者索取更多资源

Objective: To identify the characteristics of fear of cancer recurrence (FCR) in cervical cancer survivors (CCSs) and investigate the relationship of FCR with demographic and medical characteristics, level of quality of life (QOL), and psychological distress. We also aimed to determine the predictors of FCR. Methods: The short version of the Fear of Progression Questionnaire (FoP-Q-SF), the Hospital Anxiety and Depression Scale (HADS), and the Functional Assessment of Cancer Therapy-Cervical (FACT-Cx) questionnaire were administered to 699 CCSs who had complete treatment at Songklanagarind Hospital between 2006 and 2016. Analysis was performed to determine potential predictors associated with FCR. Results: Among the 12 items of the FoP-Q-SF, the 3 greatest fears were 1) worrying about what would happen to their family; 2) being afraid of pain; and 3) fear of disease progression. The prevalences of anxiety and depression disorder were 20.46% and 9.44%, respectively. CCSs who had FCR at the 5th quintile were more likely to have medical co-morbidities, low FACT-Cx scores in all domains and a high HADS scores (anxiety and depression disorder). Multivariate analysis showed that only anxiety disorder (odds ratio [OR]=4.99; p<0.001) and low FACT-Cx score (total) (OR=6.14; p<0.001) were identified as independent predictors for FCR at the 5th quintile. Conclusion: FCR is an important problem in cervical cancer which should be addressed during post-treatment care. Only anxiety disorder and low QOL were independently associated with high FCR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

Cost-utility analysis of adjuvant chemotherapy after concurrent chemoradiation in patients with locally advanced cervical cancer

Kanisa Rongsriyam, Siriwan Tangjitgamol, Pattara Leelahavarong, Yot Teerawattananon, Ekkasit Tharavichitkul, Chokaew Tovanabutra, Tussawan Asakij, Kannika Paengchit, Jirasak Sukhaboon, Somkit Penpattanagul, Lieutenant Col. Apiradee Kridakara, Jitti Hanprasertpong, Jakkapan Khunnarong, Taywin Chottetanaprasith, Vichan Lorvidhaya

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2020)

Review Oncology

Molecular insights and clinical impacts of extracellular vesicles in cancer

Kittinun Leetanaporn, Jitti Hanprasertpong, Raphatphorn Navakanitworakul

Summary: Cell-to-cell communication is crucial in cancer biology, with extracellular vesicles (EVs) playing essential roles in intercellular communications between cancer cells and the surrounding microenvironment. EVs are small membrane-bound vesicles containing various molecules that contribute to cancer cell development and progression.

ONCOLOGY REVIEWS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of chemotherapy cycles on oncological outcomes in elders with locally advanced cervical cancer treated with concurrent chemoradiotherapy

Aimwarin Tangkananan, Pitchaya Thongkhao, Narumon Janmunee, Jitti Hanprasertpong

Summary: This study investigated the association between chemotherapy cycles and oncological outcomes in elders with locally advanced cervical cancer. The results demonstrated that receiving 5-6 cycles of chemotherapy concurrently with radiotherapy improved progression-free survival and overall survival in these patients. However, the benefit of this treatment strategy was observed only within the first 2.5 years.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2022)

Article Obstetrics & Gynecology

Microsatellite instability and oncological outcomes in Thai patients with endometrial cancer

Thiti Atjimakul, Panote Wattanapaisal, Supaporn Suwiwat, Worrawit Wanichsuwan, Jitti Hanprasertpong

Summary: This study determined the frequency of microsatellite instability (MSI) and the impact of MSI-high (MSI-H) on clinical outcomes of Thai patients with endometrial cancer (EC). The results showed that MSI-H group patients had synchronous and metachronous cancer and demonstrated better 3-year disease-free survival (DFS) and overall survival compared to MSI-S group patients. Factors such as lower uterine involvement, myometrial invasion, lymphovascular space invasion, and MSI-S were identified as prognostic factors for DFS. The prevalence of mismatch repair (MMR) gene deficiency in Thai patients with EC was found to be common and associated with better outcomes.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Oncology

Predictive Value of the Hemoglobin-Albumin- Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients

Kittinun Leetanaporn, Jitti Hanprasertpong

Summary: This study found that the HALP inflammatory index can serve as an independent predictor of oncological outcomes in patients with locally advanced cervical cancer. Adding the HALP index to the predictive model improves accuracy.

CANCER MANAGEMENT AND RESEARCH (2022)

Article Obstetrics & Gynecology

Clinical Outcomes and Their Prognostic Factors among Cervical Cancer Patients with Bone Recurrence

Thiti Atjimakul, Jitti Hanprasertpong

Summary: Bone recurrence in cervical cancer patients is rare and associated with poor survival. Age and recurrence-free interval are significant prognostic factors for overall survival in cervical cancer patients with bone recurrence.

OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2022)

Article Oncology

Late recurrence of locally advanced cervical cancer treated with concurrent chemoradiotherapy

Narumon Janmunee, Aimwarin Tangkananan, Pitchaya Thongkhao, Jitti Hanprasertpong

Summary: This study compared clinicopathological factors between late-recurrence and early-recurrence patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Late recurrence at >= 3 years was not rare, with stage III-IVA being the only independent risk factor associated with late recurrence at >= 3 years. Long-term follow-up should be considered for more advanced stages, as 2.2% of patients still had late recurrence after 5 years.

ONCOLOGY IN CLINICAL PRACTICE (2022)

Article Obstetrics & Gynecology

Impact of appendectomy of a grossly normal appendix on the survival outcomes of mucinous ovarian carcinomas in a tertiary hospital

Krantarat Peeyananjarassri, Kulisara Nanthamongkolkul, Ingporn Jiamset, Wuttipong Chusook, Sathana Boonyapipat, Rakchai Buhachat

Summary: This study aimed to evaluate the impact of appendectomy on survival outcomes in patients with mucinous ovarian carcinomas. A retrospective analysis was conducted on patients who underwent primary surgery between 2002 and 2022, and the results showed that the overall survival and progression-free survival were better in the appendectomy group compared to the non-appendectomy group. Appendectomy was not found to be an independent prognostic factor for overall survival and progression-free survival in patients with mucinous ovarian carcinomas.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Obstetrics & Gynecology

Secondary Erythrocytosis Associated with Uterine Myoma Is Rare but Should Be of Concern

Ekasak Thiangphak, Ingporn Jiamset, Phawat Matemanosak, Athithan Rattanaburi

Summary: Myomatous erythrocytosis syndrome (MES) is a rare gynecological condition characterized by erythrocytosis, uterine fibroids, and normalization of red blood cell counts after surgical removal of fibroids. We report a postmenopausal woman with MES who had a history of erythrocytosis and underwent phlebotomy prior to surgery. All hematologic parameters returned to normal values on post-operative day 1, and completely normalized 4 weeks after surgery.

CASE REPORTS IN OBSTETRICS AND GYNECOLOGY (2023)

Article Obstetrics & Gynecology

Comparative outcomes between transvaginal endoscopic hysterectomy and total laparoscopic hysterectomy in patients with benign uterine disease: A single-center, retrospective, cohort, interrupted time-series study

Ingporn Jiamset, Pawara Uttraporn, Yuthasak Suphasynth

Summary: This study compared the surgical outcomes of total laparoscopic hysterectomy (TLH) and transvaginal endoscopic hysterectomy (TVEH) for benign uterine diseases. The results showed that patients in the TVEH group had shorter operative time, shorter hospital length of stay, lower morphine use, and lower postoperative febrile morbidity rates compared to the TLH group. Therefore, TVEH can be considered as an alternative hysterectomy procedure for patients with benign uterine diseases.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Oncology

Exploration of extracellular vesicle long non-coding RNAs in serum of patients with cervical cancer

Piyatida Molika, Rassanee Bissanum, Komwit Surachat, Kovit Pattanapanyasat, Jitti Hanprasertpong, Wilaiwan Chotigeat, Raphatphorn Navakanitworakul

Summary: Cervical cancer is a common type of cancer in women and a leading cause of cancer-related deaths. This study found that the expression profiles of lncRNAs in extracellular vesicles change during the development of cervical cancer, and these lncRNAs are associated with important pathways involved in cell proliferation, inflammation, and cancer progression. Some of the highly expressed lncRNAs are also associated with poor overall survival of cervical cancer patients.

ONCOLOGY (2023)

Article Obstetrics & Gynecology

A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a care in Southern Thailand

Kulisara Nanthamongkolkul, Pacharadol Taweerat, Ingporn Jiamset

Summary: This study aimed to develop a nomogram for predicting 3-year overall survival and outcomes for patients with uterine carcinosarcomas. The clinicopathological characteristics, treatment data, and oncological outcomes of 69 patients were analyzed to identify significant prognostic factors for overall survival and develop the nomogram. The nomogram, integrating body mass index, FIGO stage, and adjuvant chemotherapy, accurately predicted the 3-year overall survival of patients with uterine carcinosarcomas.

OBSTETRICS & GYNECOLOGY SCIENCE (2023)

Article Oncology

Association between resting heart rate and oncological outcomes in patients with early-stage cervical cancer who have undergone radical hysterectomy with pelvic lymphadenectomy

Kriengsak Dhanaworavibul, Kittinun Leetanaporn, Panote Wattanapaisal, Kittiya Deevongkij, Chutinun Leelarujijaroen, Jitti Hanprasertpong

Summary: This study explores the association between resting heart rate (RHR) and oncological outcomes in patients with early-stage cervical cancer. It is found that RHR is significantly positively correlated with tumor size and deep stromal invasion. Multivariate analysis shows that RHR is an independent prognostic factor for disease-free survival and overall survival in patients with early-stage cervical cancer. Patients with RHR of 71-76 bpm and >76 bpm have a higher likelihood of disease-free survival and overall survival compared to those with RHR <= 70 bpm.

ONCOLOGY RESEARCH AND TREATMENT (2023)

Article Biotechnology & Applied Microbiology

Safety and Prognostic Impacts of Ovarian Preservation during Radical Hysterectomy for Early-Stage Adenocarcinoma and Adenosquamous Cervical Cancer

Arisa Theplib, Jitti Hanprasertpong, Kittinun Leetanaporn

BIOMED RESEARCH INTERNATIONAL (2020)

Article Oncology

A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial

Siriwan Tangjitgamol, Ekkasit Tharavichitkul, Chokaew Tovanabutra, Kanisa Rongsriyam, Tussawan Asakij, Kannika Paengchit, Jirasak Sukhaboon, Somkit Penpattanagul, Apiradee Kridakara, Jitti Hanprasertpong, Kittisak Chomprasert, Sirentra Wangtikitkoon, Thiti Atjimakul, Piyawan Pariyawateekul, Kanyarat Katanyoo, Prapai Tanprasert, Wanwipa Janweerachai, Duangjai Sangthawan, Jakkapan Khunnarong, Taywin Chottetanaprasith, Busaba Supawattanabodee, Prasert Lertsanguansinchai, Jatupol Srisomboon, Wanrudee Isaranuwatchai, Vichan Lorvidhaya

JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)

暂无数据